(2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R)-3,5,6-trihydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Term ID

CHEBI:152793

Synonyms

beta-D-galacto-hexopyranosyl-(1->3)-[beta-D-galacto-hexopyranosyl-(1->6)]-D-galacto-hexopyranose
Gal(b1-3)[Gal(b1-6)]Gal
WURCS=2.0/2,3,2/[a2112h-1x_1-5][a2112h-1b_1-5]/1-2-2/a3-b1_a6-c1

Definition

References

GlyGen:G64079RT
GlyTouCan:G64079RT

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R)-3,5,6-trihydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype where environments contain (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R)-3,5,6-trihydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R)-3,5,6-trihydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Phenotype affecting (2R,3R,4S,5R,6R)-2-(Hydroxymethyl)-6-[[(2R,3S,4S,5R)-3,5,6-trihydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol

Human Disease Model